These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33835210)

  • 21. The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis.
    Sørensen K; Baevre MS; Tomter G; Llohn AH; Hagen KG; Espinosa A; Jacobsen B; Arsenovic MG; Sørvoll IH; Ulvahaug AN; Sundic T; Akkök ÇA
    Transfus Med; 2021 Oct; 31(5):314-321. PubMed ID: 33821537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.
    Londero D; Merluzzi S; Dreossi C; Barillari G
    Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal RHD genotyping in Croatia: preliminary results.
    Bingulac-Popović J; Babić I; Đogić V; Kundid R; Simović Medica J; Mišković B; Jukić I
    Transfus Clin Biol; 2021 Feb; 28(1):38-43. PubMed ID: 33227453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
    Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M
    PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
    Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB; Barrett AN;
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA.
    Rather RA; Dhawan V; Saha SC
    Indian J Med Res; 2019 Jul; 150(1):62-66. PubMed ID: 31571630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care.
    Turner MJ; Martin CM; O'Leary JJ
    Eur J Obstet Gynecol Reprod Biol; 2003 May; 108(1):29-32. PubMed ID: 12694966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.
    Clausen FB; Steffensen R; Christiansen M; Rudby M; Jakobsen MA; Jakobsen TR; Krog GR; Madsen RD; Nielsen KR; Rieneck K; Sprogøe U; Homburg KM; Baech J; Dziegiel MH; Grunnet N
    Prenat Diagn; 2014 Oct; 34(10):1000-5. PubMed ID: 24860987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care.
    Clausen FB
    Prenat Diagn; 2014 May; 34(5):409-15. PubMed ID: 24431264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
    Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
    Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience.
    Parchure D; Madkaikar M; Kulkarni S
    Blood Transfus; 2022 May; 20(3):235-244. PubMed ID: 33819144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive fetal RhD status determination in early pregnancy.
    Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
    Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.